300482 万孚生物
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额200,359328,6791,682,171664,9301,061,837
投资活动产生之现金流量净额(1,143,805)(113,395)(1,560,905)(785,427)(1,027,864)
筹资活动产生之现金流量净额495,297(542,023)35,332(270,936)502,659
汇率变动对现金及现金等价物的影响1,5515,8808,626(20,246)(8,633)
现金及现金等价物净增加/(减少)(446,597)(320,860)165,224(411,678)527,999
期初现金及现金等价物余额839,5781,160,437995,2131,406,892878,893
期末现金及现金等价物余额392,981839,5781,160,437995,2131,406,892